Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Track Amy Shah's next role move, team hires, and deals — with verified, ICP-scored contact reveals (email + mobile) on demand at every company involved.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Rvl Pharmaceuticals Appoints Lori Deo As Chief Executive Officer and Amy Shah As Chief Growth Officer

PRIVATENov 24, 2025•6 months ago

Position

Chief Growth Officer

Company

RVL Pharmaceuticals plc

Amy Shah
Bridgewater

Description

RVL Pharmaceuticals has announced the appointment of Lori Deo as CEO and Amy Shah as Chief Growth Officer. These changes aim to enhance the company's growth strategy and strengthen its market position.

Company Information

Company

RVL Pharmaceuticals plc

Location

Rvl

Bridgewater, New Jersey, United States

About

RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

Predictive Intelligence
Strategic

ML-powered predictions for RVL Pharmaceuticals plc's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.